Plasmodium vivax: Comparison of the immune responses between oral and parenteral immunization of rPv54 in BALB/c mice

Experimental Parasitology

Volumn 126, Issue 2, 2010, Pages 217-223

  Kwon, Myoung Hee ^a,c   Kim, Hyung Hwan ^b,f   Lee, Ho Sa ^c   Kim, Tong Soo ^d   Oh, Chang Mi ^a   Ahn, Yong Joo ^b   Hwang, Seo Kyong ^b   Sohn, Youngjoo ^e   Kim, Hyuck ^f   Lee, Hyeong Woo ^a,g  

^a Korea Centers for Disease Control and Prevention   (South Korea)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Kyung Hee University   (South Korea)

^d Inha University School of Medicine   (South Korea)

^e Department of Computer and Electronic Physics   (South Korea)

^f International Research Center of Bioscience and Biotechnology   (South Korea)

^g UNIVERSITY OF FLORIDA   (United States)

Author keywords

ICB10; Merozoite surface protein 1; Oral immunization; Plasmodium vivax

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERSPECIES CONSERVED BLOCK 10 PROTEIN; MALTOSE BINDING PROTEIN; MEROZOITE SURFACE PROTEIN 1; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BACTERIUM ISOLATE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; KOREA; MOLECULAR CLONING; MOLECULAR WEIGHT; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFUSIONS, PARENTERAL; INTERLEUKIN-5; MALARIA, VIVAX; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; PERIPLASMIC BINDING PROTEINS; PLASMODIUM VIVAX; PROTOZOAN VACCINES; RECOMBINANT FUSION PROTEINS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, SYNTHETIC;

ESCHERICHIA COLI; MUS; PLASMODIUM VIVAX;

EID: 77955275744     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.05.001     Document Type: Article

References (50)

1. Arakawa T., Chong D.K., Langridge W.H. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nature Biotechnology 1998, 16:292-297.
2. Barker R.H., Banchongaksorn T., Courval J.M., Suwonked W., Rimwungtragoon K., Wirth D.F. A simple method to detect Plasmodium falciparum directly from blood samples using the polymerase chain reaction. American Journal of Tropical Medicine and Hygiene 1992, 46:416-426.
3. Braga E.M., Barros R.M., Reis T.A., Fontes C.J., Morais C.G., Martins M.S., Krettli A.U. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. American Journal of Tropical Medicine and Hygiene 2002, 66:461-466.
4. Brown A.E., Kain K.C., Pipithkul J., Webster K. Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy. Transactions of the Royal Society of Tropical Medicine and Hygiene 1992, 86:609-612.
5. Caro-Aguilar I., Rodriguez A., Calvo-Calle J.M., Guzman F., De la Vega P., Patattoyo M.E., Galinski M.R., Moreno A. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Infection and Immunity 2002, 70:3479-3492.
6. Chai I.H., Lim G.I., Yoon S.N., Oh W.I., Kim S.J., Chai J.Y. Occurrence of tertian malaria in a male patient who has never been abroad. Korean Journal of Parasitology 1994, 32:195-200.
7. Cho S.Y., Kong Y., Park S.M., Lee J.S., Lim Y.A., Chae S.L., Kho W.G., Lee J.S., Shim J.C., Shin H.K. Two vivax malaria cases detected in Korea. Korean Journal of Parasitology 1994, 32:281-284.
8. del Portillo H.A., Longacre S., Khouri E., David P.H. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:4030-4034.
9. Engers H.D., Godal T. Malaria vaccine development; current status. Parasitology Today 1998, 14:56-64.
10. Good M.F., Kaslow D.C., Miller L.H. Pathways and strategy for developing a malaria blood-stage vaccine. Annual Review of Immunology 1998, 16:57-87.
11. Groux H., Gysin J. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Research in Immunology 1990, 141:529-542.
12. Hoffman S.L., Rogers W.O., Carucco D.J., Venter J.C. From genomics to vaccines: malaria as model system. Nature Medicine 1998, 4:1351-1353.
13. Holder A.A. The precursor to major merozoite surface antigens: structure and role in immunity. Progress in Allergy 1988, 41:72-97.
14. Hunter R.L., Kidd M.R., Olsen M.R., Patterson P.S., Lal A.A. Induction of long lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. Journal of Immunology 1995, 154:1762-1769.
15. Ishimoto Y., Tomiyama-Miyaji C., Watanabe H., Yokoyama H., Ebe K., Tsubata S., Aoyagi Y., Abo T. Age-dependent variation in the proportion and number of intestinal lymphocyte subsets, especially natural killer T cells, double-positive CD4+ CD8+ cells and B220+ T cells, in mice. Immunology 2004, 113:371-377.
16. Kain K.C., Brown J.A.E., Mirabelli L., Webster H.K. Detection of Plasmodium vivax by polymerase chain reaction in a field study. Journal of Infectious Diseases 1993, 168:1323-1326.
17. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., Agarwal A. Heme oxygenase-1 modulates early inflammatory responses evidence from the heme oxygenase-1-deficient mouse. American Journal of Pathology 2004, 165:1045-1053.
18. Keum J.C., Iem C.H., Lee S.J., Kim K.H. The effect of Gagamtonsun-san on the tumor and immune response in mouse B16 melanoma tumor model. Journal of Oriental Medicine 2001, 6:27-40.
19. Khan S.S., Smith M.S., Reda D., Suffredini A.F., McCoy J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry Part B (Clinical Cytometry) 2004, 61B:35-39.
20. Kim H.C., Pacha L.A., Lee W.J., Lee J.K., Gaydos J.C., Sames W.J., Lee H.C., Bradley K., Jeung G.G., Tobler S.K., Klein T.A. Malaria in the Republic of Korea, 1993-2007. Variables related to re-emergence and persistence of Plasmodium vivax among Korean populations and U.S. Forces in Korea. Military Medicine 2009, 174:762-769.
21. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. Journal of Cell Biology 1991, 115:887-903.
22. Lee J.S., Kho W.G., Lee H.W., Seo M., Lee W.J. Current status of vivax malaria among civilians in Korea. Korean Journal of Parasitology 1998, 36:241-248.
23. Lee J.S., Lee W.J., Cho S.H., Ree H.I. Outbreak of vivax malaria in areas adjacent to the demilitarized zone, South Korea, 1998. American Journal of Tropical Medicine and Hygiene 2002, 66:13-17.
24. Levitus G., Mertens F., Speranca M.A., Camargo L.M., Ferreira M.U., del Portillo H.A. Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax. American Journal of Tropical Medicine and Hygiene 1994, 51:68-76.
25. Lim C.S., Kim S.H., Kwon S.I., Song J.W., Song K.J., Lee K.N. Analysis of Plasmodium vivax merozoite surface protein-1 gene sequences from resurgent Korean isolates. American Journal of Tropical Medicine and Hygiene 2000, 62:261-265.
26. Lim K.J., Park J.W., Yeom J.S., Lee Y.H., Yoo S.B., Oh J.H., Sohn M.J., Bahk Y.Y., Kim Y.S. Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax. Parasitology Research 2004, 92:384-389.
27. Mancilla L.I., Levitus G., Kirchatter K., Mertens F., Herrera S., del Portillo H.A. Plasmodium vivax: dimorphic DNA sequences from the MSP-1 gene code for regions that are immunogenic in natural infections. Experimental Parasitology 1994, 79:148-158.
28. Marsh K., Otoo L., Hayes R.J., Carson D.C., Greenwood B.M. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relations to protection against infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 1989, 83:293-303.
29. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nature Review 2003, 3:331-341.
30. National Malaria Eradication Service, 1966. Malaria pre-eradication program in Korea. Progress report 1961-1965. Ministry of Health and Social Affairs, Republic of Korea, pp. 44-70.
31. Naumov Y.N., Bahjat K.S., Gausling R., Abraham R., Exley M.A., Koezuka Y., Balk S.B., Strominger J.L., Clare-Salzer M., Wilson S.B. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:13838-13843.
32. Ndungu F.M., Bull P.C., Ross A., Lowe B.S., Kabiru E., Marsh K. Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunology 2002, 24:77-82.
33. Paik Y.H., Ree H.I., Shim J.C. Malaria in Korea. The Japanese Journal of Experimental Medicine 1988, 58:55-66.
34. Park J.W., Moon S.H., Yeom J.S., Lim K.J., Sohn M.J., Ki C.S., Oh M.D., Choe W.G. Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea. Clinical and Diagnostic Laboratory Immunology 2001, 8:14-20.
35. Park J.W., Klein T.A., Lee H.C., Pacha L.A., Ryu S.H., Yeom J.S., Moon S.H., Kim T.S., Chai J.Y., Oh M.D., Choe K.W. Vivax malaria: a continuing health threat to the Republic of Korea. American Journal of Tropical Medicine and Hygiene 2003, 69:159-167.
36. Pasay M.C., Cheng Q., Rzepczyk C., Saul A. Dimorphism of the C terminus of the Plasmodium vivax merozoite surface protein 1. Molecular and Biochemical Parasitology 1995, 70:217-219.
37. Pinto A.Y., Ventura A.M., Souza J.M. IgG antibody response against Plasmodium vivax in children exposed to malaria, before and after specific treatment. Jornal de Pediatria 2001, 77:299-306.
38. Ree H.I. Unstable vivax malaria in Korea. Korean Journal of Parasitology 2000, 38:119-138.
39. Sachdeva S., Ahmad G., Malhotra P., Mukherjee P., Chauhan V.S. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infection and Immunology 2004, 72:5775-5782.
40. Shi Y.P., Sayed U., Qari S.H., Roberts J.M., Udhayakumar V., Oloo A.J., Hawley W.A., Kaslow D.C., Nahlen B.L., Lal A.A. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infection and Immunology 1996, 64:2716-2723.
41. Skold M., Behar S.M. Role of CD1d-restricted NKT cells in microbial immunity. Infection and Immunology 2003, 71:5447-5455.
42. Soares I.S., Levitus G., Souza J.M., del Portillo H.A., Rodrigues M.M. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infection and Immunology 1997, 65:1606-1614.
43. Soh J.T., Lee K.T., Im K.I., Min D.Y., Ahn M.H., Kim J.J., Yong T.S. Current status of malaria in Korea. Yonsei Report on Tropical Medicine 1985, 16:11-18.
44. Sun J.B., Holmgren J., Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:10795-10799.
45. Taylor R.R., Allen S.J., Greenwood B.M., Riley E.M. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. American Journal of Tropical Medicine and Hygiene 1998, 58:406-413.
46. Taylor-Robinson A.W., Phillips R.S., Severn A., Moncada S., Liew F.Y. The role of TH1 and TH2 cells in a rodent malaria infection. Science 1993, 260:1931-1934.
47. Tirasophon W., Rajkulchai P., Ponglikitmongkol M., Wilairat P., Boonsaeng V., Panyim S. A highly sensitive, rapid, and simple polymerase chain reaction-based method to detect human malaria (Plasmodium falciparum and Plasmodium vivax) in blood samples. American Journal of Tropical Medicine and Hygiene 1994, 51:308-313.
48. Tsang V.C.W., Peralta J.M., Simons A.R. Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods in Enzymology 1983, 92:377-391.
49. Wahlgren M., Perlmann H., Berzins K., Bjorkman A., Larsson A., Ljungstrom I., Patarroy E.M., Perlmann P. Characterization of the humoral immune response in Plasmodium falciparum malaria. III. Factors influencing the coexpression of antibody isotypes (IgM and IgG-1 to 4). Clinical and Experimental Immunology 1986, 63:343-353.
50. Wang L., Kedzierski L., Wesselingh S.L., Coppel R.L. Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria. Infection and Immunology 2003, 71:2356-2364.